[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,358
Citations 0
Comment & Response
July 24/31, 2018

Procalcitonin to Guide Antibiotic Decisions

Author Affiliations
  • 1Department of Emergency Medicine, David Geffen School of Medicine at University of California, Los Angeles
JAMA. 2018;320(4):406. doi:10.1001/jama.2018.6713

To the Editor In a JAMA Clinical Evidence Synopsis article, Dr Schuetz and colleagues1 summarized their recent Cochrane review2 of outcomes associated with procalcitonin-guided antibiotic treatment of patients with acute upper and lower respiratory tract infections vs usual care. The article is confusing in that it does not address why there would be an associated survival benefit, especially when no such association has been found for its use to manage patients with sepsis.3